When taken together with the data presented herein, human dysferlinopathies, which result in LGMD2B and MM, could be another type of MD with characteristic dyslipidemia (White et al., 2020). The gene discussed is DYSF; the disease is neuromuscular disease caused by qualitative or quantitative defects of dysferlin.